Table III.
Comparison of the baseline information between the TS and TACE groups.
| Parameters | TS group | TACE group |
|---|---|---|
| Sex, male/female | 8/2 | 7/3 |
| Average age, years | 55 | 50 |
| BCLC grade | C | C |
| Prothrombin time activity, sec | 13.9 (12.7–16.2) | 14.9 (13.2–16.6) |
| Total bilirubin, µmmol/l | 16.3 (8.6–32.8) | 16.9 (7.9–29.0) |
| Hemoglobin, g/l | 127.0 (106.0–177.0) | 124.0 (104.0–140.0) |
| Alanine transaminase, U | 78.2 (38.0–95.5) | 72.4 (54.3–89.2) |
| Aspartate aminotransferase, U | 57.1 (25.0–84.0) | 60.1 (33.0–83.8) |
BCLC, Barcelona Clinic Liver Cancer grade; TACE, transarterial chemoembolization; TS group, TACE combined with sorafenib. Data are presented as mean (range).